Immunotherapy of Malignant Tumors Using Antisense Anti-IGF-I Approach: Case of Glioblastoma

Home > Journals > Medicine & Healthcare >JCT

ISSN Print: 2151-1934
ISSN Online: 2151-1942

Website: https://www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

Submission

"Immunotherapy of Malignant Tumors Using Antisense Anti-IGF-I Approach: Case of Glioblastoma"
written by Annabelle Trojan, Lina M. Jay, Heliodor Kasprzak, Donald D. Anthony, Jerzy Trojan,
published by Journal of Cancer Therapy, Vol.5 No.7, 2014

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Neoplastic Brain, Glioblastoma, and Immunotherapy
	2020

[2]	Hyperthyroidism
	2020

[3]	Oncoproteins Targeting: Antibodies, Antisense, Triple-helix. Case of Anti IGF-I Cancer Immunogene Therapy
	2019

[4]	Epistemológica experiencia en la elaboración de tecnología biomolecular para estrategia de la inmunoterapia génica
	2016

[5]	Growth factors and kinases in glioblastoma growth
	2016

[6]	Experiencia epistemologica en la elaboracion de tecnologia biomolecular como estrategia de la inmunoterapia genica/Epistemological experience in developing of …
	2016

[7]	Epistemológica experiencia en la elaboración de tecnología biomolecular para estrategia de la inmunoterapia génica-Epistemological experience in the …
	2016

[8]	Experimental gene therapy of CNS neoplasia–IGF-I target


[9]	Diagnostic of CNS neoplasia–AFP and IGF-I targets


[10]	Clinical gene therapy of brain tumor–glioblastoma


[11]	Twenty-Five Years of Cancer Immunogene Therapy: Anti-Gene IGF-I Approach

● Open Special Issues

● Published Special Issues

● Special Issues Guideline

JCT Subscription

E-Mail Alert

JCT Most popular papers

Publication Ethics & OA Statement

JCT News

Frequently Asked Questions

Follow SCIRP

Journals A-Z

Journals by Subject

Manuscript Tracking System

Open Access

Books

For Authors

Translation & Proofreading

Submission System Login

Sitemap

Peer-Review Resources

Frequently Asked Questions

Advertising

News

Volume & Issue

[1]	Brain and Spinal Tumors - Primary and Secondary 2020 DOI:10.5772/intechopen.84726

[2]	Antisense Therapy [Working Title] 2019 DOI:10.5772/intechopen.82548